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INTRODUCTION
Candidiasis occurs in organ transplanted 
patients that are in immunosuppression treatment 
and carriers of acquired immunodeficiency 
virus2,3,5,8,26,30. If disseminated, these infections are 
related to high morbidity and mortality levels1,20. 
Candida albicans is the etiological agent of most 
of oropharyngeal candidiasis cases associated with 
immunosuppression, although infections caused 
by C. tropicalis and C. dubliniensis have also been 
reported13,21.
A heart transplant patient undergoing 
immunosuppressive therapy receives cyclosporine, 
azathioprine and prednisone or tacrolimus (FK506), 
C andida spp. can lead to infections or even fungal sepsis particularly among immunocompromized individuals. Objective: The aim of the present study was to 
analyze the presence of Candida spp. among patients subjected to orthotopic heart 
transplantation. Material and Methods: Oral rinses from 50 patients subjected to orthotopic 
heart transplantation, aged 13 to 70 years, 40 males and 10 females, were examined. Sex-
age-oral conditions matched-control included 50 individuals who were not subjected to any 
kind of transplantation and were not immunocompromized for any other reason. Counts 
of yeasts were expressed as median values of logarithm of cfu/mL and were statistically 
compared by Mann-Whitney’s test. The heart transplant and control groups were compared 
for the presence of Candida spp. by chi-square test (p<0.05). Results: The results showed 
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transplantation and control groups. Counts of yeasts (cfu/mL) in the transplanted group 
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	Candida albicans was the 
most prevalent species isolated from both groups. Conclusions: It was concluded that 
Candida yeast counts were higher in the heart transplant recipients than in the controls. 
There was higher variation of Candida species among the heart transplant patients and the 
most frequently isolated samples were: Candida albicans, Candida glabrata and Candida 
tropicalis. Isolates of Candida dubliniensis was not found in either of the groups.
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and rapamycin, among others10,26. The main causes 
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year following heart transplantation, are infection 
and rejection6,26. The incidence of fungal infection 
in patients receiving a heart transplant varies 
between 10% and 25%. Extreme cases have also 
been reported, where the cause of death was fungal 
sepsis5,6. The levels of Candida spp. in the oral cavity 
of heart transplant recipients can lead to a better 
understanding of the relationship among host, 
immunosuppression and the fungus development, 
improving the quality of life of these patients. The 
present study evaluated the prevalence of Candida 
spp. in the oral cavity of orthotopic heart transplant 
recipients.
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MATERIAL AND METHODS
Ethic Aspects
This study was approved by the Research Ethics 
Committee of the São José dos Campos Dental 
School/UNESP (060/2001 PH/CEP) and the Medical 
School of the University of São Paulo/INCOR/
HCFMUSP (1004/01).
Subjects
Inclusion criteria
One-hundred individuals were included in this 
study. Fifty patients were recipients of orthotopic 
heart transplantation, aged 13 to 70 years (mean 
age=48.6 years), 40 males (80%) and 10 females 
(20%). These patients received immunosuppressive 
therapy for a minimum period of 2 months and were 
under clinical follow-up at Univeristy of São Paulo 
Medical School’s Heart Institute (INCOR/HCFMUSP).
Sex-age-oral conditions matched control group 
included 50 individuals who were not subjected to 
any kind of organ transplantation. These individuals 
were aged 13 to 70 years (mean age=47.5 years), 
40 males (80%) and 10 females (20%), with 
the closest oral conditions to those of the heart 
transplant patients (regarding the use of denture 
or orthodontic appliances). These individuals were 
under treatment at São José dos Campos Dental 
School, São Paulo State University, Brazi.
Exclusion criteria
Patients who presented clinical symptoms of oral 
candidiasis or were under antifungal or antibacterial 
therapy were excluded from the study. Patients 
under any kind of immunosuppressive therapy were 
excluded from the control group.
Oral Rinse Collection
Each individual received 10 mL of sterile 
phosphate-buffered saline (PBS; 0.1 M and pH 
7.2) supplied in a disposable universal sterile 
container. They were required to mouthwash for 30 
s and collect the oral rinse back into the previously 
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ice in a thermal bag, and was forwarded to the 
microbiology laboratory within a maximum time 
span of 3 h between sampling and processing. 
Each sample was centrifuged at 2,300 xg for 10 
min (Centrifuge MPW-350R; Biosystems, São José 
dos Pinhais, PR, Brazil) and the supernatant was 
discharged. Then, the deposit was resuspended in 
2.5 mL of PBS and mixed in a vortex equipment 
(Phoenix, model AP56, Araraquara, SP, Brazil) 
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suspension.
Collection of Yeast Isolates
An amount of 0.1 mL from all obtained suspensions 
was cultured in duplicate on Sabouraud dextrose 
agar (Difco Laboratories, Detroit, MI, USA) with 
chloramphenicol (0.1 mg/mL of culture medium) 
and also in duplicate on CHROMagar (CHROMagar; 
Microbiology, Paris, France). Plates were incubated 
at 37°C for 48 h and kept at room temperature for 
the following 5 days. After, the number of colony-
forming unities per mililiter (cfu/mL) of yeasts was 
calculated. Stained smears were obtained by Gram 
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were transferred to Sabouraud dextrose agar, so as 
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All cfu that showed different color or morphology 
in CHROMagar were isolated.
Candida	
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on colonies morphology and colour observed in 
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according to Samaranayake and Macfarlane24 (1990) 
and Sandvén25 (1990). The following tests were 
performed: germ-tube production, chlamidoconidia, 
hyphae/pseudohyphae production on Corn Meal 
agar (Difco), carbohydrate fermentation and 
assimilation. Orange-red colonies with Rhodotorula 
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	$		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(Polymerase Chain Reaction - PCR)
&				C. albicans 
or C. dubliniensis were subjected to molecular 
detection of C. dubliniensis. These isolates were 
analyzed by PCR, according to the methodology 
proposed by Donnelly, et al.7 (1999) and Mähnb, et 
al.16	@			QV			
were plated on Sabouraud dextrose agar and 
incubated for 24 h at 37°C. Then, a single colony 
was transferred to 75 mL of zymoliase (0.5 mg/mL) 
(Sigma, St. Louis, MO, USA) solution (0.5 mg/mL 
in 1 M sorbitol buffer). Tubes were maintained at 
95°C for 10 min. After this period, samples were 
centrifuged at 8.000 xg at 4°C for 15 min and the 
supernatant was kept on ice until the PCR analyses.
For  PCR,  two pa i rs  o f  pr imers  were 
u s e d :  t w o  u n i v e r s a l  p r i m e r s ,  U n i - f : 
5’-GCATATCAATAAGCGGAGGAAAAG-3’ and 
Uni-r: 5’GGTCCGTGTTTCAAGACG-3’; and two 
C. dubliniensis-specific ones, DUBF Act-f: 
5’GTATTTGTCGTTCCCCTTTC-3’ and DUBR Act-r: 
XYZ!Z!!Z!Z!Z'['![['Z!'Y#X	!		
was carried out in a 10 \			
	
	 	 	 	 	 L PCR Master Mix 
(Promega, Madison, WI, USA), 3.2 L of ultra-pure 
water and 1 L of DNA template. Cycling conditions 
consisted of 3 min at 95°C followed by 30 cycles of 
30 s at 95°C, 30 s at 58°C, 60 s at 72°C, followed 
by 72°C for 10 min (Mastercycler, Eppendorf, 
Hamburg, Germany). In all reactions, C. albicans 
(ATCC 18804) and C. dubliniensis (NCPF 3108) were 
	 	 	 [	 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separated by electrophoresis through 2% (w/v) 
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agarose gels containing 25 M ethidium bromide 
(Sigma) and visualized on a UV transilluminator 
(Foto/UV 26; Bioresearch, Upland, CA, USA). A DNA 
“ladder” 100 pb (BRL; Gibco, Gaithrsbur, MD, USA) 
was used as molecular size standard. The gels were 
photographed for documentation (Kodak Photo 
Documentation System, DC290; Sigma).
Statistical Analysis
The heart transplant and control groups were 
compared for the presence (or absence) of Candida 
spp. by chi-square test in order to compare 
proportions.
Counts of yeasts were expressed as median 
values of logarithm of cfu/mL and were statistically 
compared by Mann-Whitney’s test, using the 
Minitab Statistical Software version 13.1 (Minitab 
Inc., State College, PA, USA). [	
		
of 5% was set for all analyses.
RESULTS
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(p=0.001) from the control group for the presence 
of Candida spp. (Table 1). There was no statistically 
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transplant and the control group for the proportion 
of the presence of C. albicans and others species.
Counts of yeasts (cfu/mL) in the transplanted 
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group (p=0.005) (Table 2).
C. albicans was the prevalent species in both 
groups of subjects. Among the transplanted 
patients, other isolated Candida species and 
Rhodotorula rubra was found. C. dubliniensis was 
not found in either of the groups. Larger counts 
of Candida species were found in the transplanted 
individuals in relation to the controls (Table 3). 
Four isolates of R. rubra were observed in the heart 
transplant group and 7 in the control group.
Associations of Candida species observed in the 
transplant recipients and controls are shown in 
Figure 1. More associations were observed in the 
transplantation group.
Groups n Positive to 
Candida spp.
Negative to
Candida spp.
Transplanted 50 44 (88%)* 6 (12%)
Control 50 28 (56%) 22(44%)
Table 1- Number and percentage of individuals positive to 
Candida spp. in the oral cavity
*Statistically different proportion in relation to the control 
(chi-square test, p=0.001)
Groups n Median 25% 75%
Transplanted 50 5.66* 4.60 6.27
Control 50 5 0 5.55
Table 2- Values of logarithm of colonies forming units per 
mililitre (log cfu/mL) in the studied groups
		
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(Mann-Whitney, p=0.005)
Species                                          Transplanted (n=67)                         Control
                                                         n                      %                       n                     %
C. albicans 31 49.21 25 75.75
C. glabrata 9 14.28 3 9.1
C. tropicalis 7 11.11 2 6.06
C. krusei 4 6.35 2 6.06
C. parapsilosis 4 6.35 - -
C. kefyr 3 4.76 - -
C. lipolitica 3 4.76 - -
C. guilliermondii 1 1.59 1 3.03
C.lusitaniae 1 1.59 - -
Total 63 100 33 100
Table 3- Candida species isolated from the oral cavity of orthotopic cardiac transplantation patients and species isolated 
from the oral cavity of control individuals
RIBEIRO PM, BACAL F, KOGA-ITO CY, JUNQUEIRA JC, JORGE AOC
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DISCUSSION
Transplantation is a treatment option for patients 
who have lost the normal function of their vital 
organs. Infectious complications are still among 
the major causes of morbidity and mortality during 
the period immediately following surgery6. Many 
authors1,9,11,21 agree that orthotopic heart transplant 
recipients show an increased prevalence of Candida 
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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	 	
According to Ruskin, et al.22 (1992), the reduction 
of Candida species in the oropharyngeal area could 
potentially decrease the incidence of disseminated 
candidiasis that is often associated to death cases 
in immunosuppressed patients9. Dictar, et al.6 
(2000), have reported that the mortality rate due 
to fungal infections in recipients of transplanted 
organs increased to 23.7%, and that 75% of these 
cases occurred among heart transplant recipients. 
Candida spp. was responsible for 29% of such 
infections.
Many s tud ies  on  immunosuppressed 
individuals1,6,9,11,15,18,29 point to C. albicans as the 
most prevalent species, which agrees with the 
results of the present study. A greater variety of 
species was found in the heart transplant group, 
				
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in literature6,9,12. Furthermore, some authors have 
reported that, in addition to C. albicans, the species 
most frequently related to immunosuppression were 
C. tropicalis, C. glabrata6 and C. dubliniensis3,11,18,27. 
In the present study, C. albicans was the most 
prevalent species, followed by C. glabrata and C. 
tropicalis. C. dubliniensis was not found in either 
of the groups. In the control group, C. albicans, 
R. rubra and C. glabrata were the most prevalent 
species.
C. dubliniensis has many phenotypic features 
with C. albicans and the incidence of candidemia 
due C. dubliniensis is unknown mainly because of 
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C. dubliniensis has been frequently associated 
to oral and systemic candidiasis in HIV-positive 
patients4,19,23 under chemotherapy and bone marrow 
transplant patients3,18, sometimes liable for death 
cases28. Thus, it is very important to identify 
among the population of immunossuppressed 
patients those who have C. dubliniensis in their 
oral microbiota, and how big is this ratio (cfu/mL).
Sabouraud dextrose agar with chloramphenicol 
and CHROMagar Candida were effective for 
Candida growth and, in both media, there was a 
higher prevalence of yeasts in the heart transplant 
group. This group presents species variation one 
third higher in relation to control group and these 
results were similar to those obtained for others 
authors6,9. Being chromogenic, CHROMagar allowed 
	 	 	 	 	 !	 	
offered a better visualization of the various shapes 
of the yeasts.
There was higher isolation (cfu/mL) on 
Sabouraud dextrose agar with chloramphenicol than 
in CHROMagar Candida for both groups. It is likely 
that this culture medium causes partial inhibition of 
some Candida isolates, which might be attributed 
to a higher selectivity of chromogenic components.
We used a reliable, simple, fast, and noninvasive 
method for studying the prevalence of Candida 
yeasts in oral cavity of patients subjected orthotopic 
heart transplantation. This method was also able 
to detect, among the studied population, those 
individuals with higher Candida cfu/mL counts 
in saliva, and who might be more susceptible 
to candidiasis development. In such cases, the 
Patients (n) Associations of Candida Species
Tx (3) C. albicans and C. parapsilosis
Tx (2) C. albicans and C. glabrata
Tx (1) C. albicans and C. kefyr
Tx (1) C. lusitaniae and C. glabrata
Tx (1) C. glabrata and C. krusei
Tx (1) C. albicans and C. guilliermondii
Tx (1) C. tropicalis and C. glabrata
Tx (1) C. albicans and C. krusei
Tx (1) C. albicans, C. tropicalis and C. kefyr
Tx (1) C. tropicalis, C. glabrata and C. lipolytica
Tx (1) C. albicans, C. tropicalis and C. krusei
Tx (1) C. albicans, C. tropicalis, C. krusei, C. glabrata and C. kefyr
C (4) C. albicans and C. glabrata
C (1) C. albicans and C. guilliermondii
C (1) C. albicans, C. tropicalis and C. krusei
Figure 1- Associations of Candida species isolated from the oral cavity of orthotopic heart transplant patients (Tx) and 
control individuals (C)
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use of a proper antifungal prophylaxis may be 
indicated, aiming at avoiding the clinical oral 
manifestation of the disease, as well as its systemic 
dissemination14,20.
CONCLUSION
The number of Candida 		
	
larger in the oral cavity of orthotopic heart transplant 
patients than in non-immunosuppressed subjects. 
There was higher prevalence of C. albicans in 
saliva isolates from both groups, but the proportion 
between this species and others was not statistically 
different. The heart transplantation group showed 
higher variation of Candida species in relation to 
the control group.
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